172 related articles for article (PubMed ID: 27100402)
1. General Practitioners' Experiences of, and Responses to, Uncertainty in Prostate Cancer Screening: Insights from a Qualitative Study.
Pickles K; Carter SM; Rychetnik L; McCaffery K; Entwistle VA
PLoS One; 2016; 11(4):e0153299. PubMed ID: 27100402
[TBL] [Abstract][Full Text] [Related]
2. Primary goals, information-giving and men's understanding: a qualitative study of Australian and UK doctors' varied communication about PSA screening.
Pickles K; Carter SM; Rychetnik L; McCaffery K; Entwistle VA
BMJ Open; 2018 Jan; 8(1):e018009. PubMed ID: 29362252
[TBL] [Abstract][Full Text] [Related]
3. Doctors' perspectives on PSA testing illuminate established differences in prostate cancer screening rates between Australia and the UK: a qualitative study.
Pickles K; Carter SM; Rychetnik L; Entwistle VA
BMJ Open; 2016 Dec; 6(12):e011932. PubMed ID: 27920082
[TBL] [Abstract][Full Text] [Related]
4. Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study.
Pickles K; Carter SM; Rychetnik L
BMJ Open; 2015 Mar; 5(3):e006367. PubMed ID: 25783420
[TBL] [Abstract][Full Text] [Related]
5. General practitioners' reflections on using PSA for diagnosis of prostate cancer. A qualitative study.
Thorsen O; Viste E; Lid TG; Kjosavik SR
Scand J Prim Health Care; 2022 Mar; 40(1):123-128. PubMed ID: 35412395
[TBL] [Abstract][Full Text] [Related]
6. PSA testing for men at average risk of prostate cancer.
Armstrong BK; Barry MJ; Frydenberg M; Gardiner RA; Haines I; Carter SM
Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765854
[TBL] [Abstract][Full Text] [Related]
7. PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK.
Brett J; Watson E; Hewitson P; Bukach C; Edwards A; Elwyn G; Austoker J
BMC Fam Pract; 2005 Jun; 6(1):24. PubMed ID: 15946386
[TBL] [Abstract][Full Text] [Related]
8. The PSA testing dilemma: GPs' reports of consultations with asymptomatic men: a qualitative study.
Clements A; Watson E; Rai T; Bukach C; Shine B; Austoker J
BMC Fam Pract; 2007 Jun; 8():35. PubMed ID: 17593306
[TBL] [Abstract][Full Text] [Related]
9. General practitioners' approaches to prostate-specific antigen testing in the north-east of the Netherlands.
Kappen S; Koops L; Jürgens V; Freitag MH; Blanker MH; Timmer A; de Bock GH
BMC Fam Pract; 2020 Dec; 21(1):270. PubMed ID: 33334312
[TBL] [Abstract][Full Text] [Related]
10. General practitioners' perceptions of population based bowel screening and their influence on practice: a qualitative study.
Dawson G; Crane M; Lyons C; Burnham A; Bowman T; Perez D; Travaglia J
BMC Fam Pract; 2017 Mar; 18(1):36. PubMed ID: 28298185
[TBL] [Abstract][Full Text] [Related]
11. Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners.
Drummond FJ; Carsin AE; Sharp L; Comber H
BMC Fam Pract; 2009 Jan; 10():3. PubMed ID: 19138385
[TBL] [Abstract][Full Text] [Related]
12. [Early detection of prostate cancer by PSA testing: the results of a qualitative study on barriers caused by physicians in Austria implementing informed decision making].
Malli G
Gesundheitswesen; 2013 Jan; 75(1):22-8. PubMed ID: 22836936
[TBL] [Abstract][Full Text] [Related]
13. PSA screening in New Zealand: total population results and general practitioners' current attitudes and practices.
van Rij S; Dowell T; Nacey J
N Z Med J; 2013 Aug; 126(1381):27-36. PubMed ID: 24150262
[TBL] [Abstract][Full Text] [Related]
14. Prescribing antibiotics to 'at-risk' children with influenza-like illness in primary care: qualitative study.
Ashdown HF; Räisänen U; Wang K; Ziebland S; Harnden A;
BMJ Open; 2016 Jun; 6(6):e011497. PubMed ID: 27288385
[TBL] [Abstract][Full Text] [Related]
15. Association of GPs' risk attitudes, level of empathy, and burnout status with PSA testing in primary care.
Pedersen AF; Carlsen AH; Vedsted P
Br J Gen Pract; 2015 Dec; 65(641):e845-51. PubMed ID: 26541183
[TBL] [Abstract][Full Text] [Related]
16. General Practitioners' and patients' perceptions towards stratified care: a theory informed investigation.
Saunders B; Bartlam B; Foster NE; Hill JC; Cooper V; Protheroe J
BMC Fam Pract; 2016 Aug; 17(1):125. PubMed ID: 27582134
[TBL] [Abstract][Full Text] [Related]
17. What factors determine Belgian general practitioners' approaches to detecting and managing substance abuse? A qualitative study based on the I-Change Model.
Ketterer F; Symons L; Lambrechts MC; Mairiaux P; Godderis L; Peremans L; Remmen R; Vanmeerbeek M
BMC Fam Pract; 2014 Jun; 15():119. PubMed ID: 24927958
[TBL] [Abstract][Full Text] [Related]
18. Primary Care Physicians Beliefs about Prostate-Specific Antigen Evidence Uncertainty, Screening Efficacy, and Test Use.
Ross LE; Hall IJ; Howard DL; Rim SH; Richardson LC
J Natl Med Assoc; 2018 Oct; 110(5):491-500. PubMed ID: 30129508
[TBL] [Abstract][Full Text] [Related]
19. Integrating evidence and individual preferences using a web-based multi-criteria decision analytic tool: an application to prostate cancer screening.
Cunich M; Salkeld G; Dowie J; Henderson J; Bayram C; Britt H; Howard K
Patient; 2011; 4(3):153-62. PubMed ID: 21766911
[TBL] [Abstract][Full Text] [Related]
20. GPs views and understanding of PSA testing, screening and early detection; survey.
Sutton J; Melia J; Kirby M; Graffy J; Moss S
Int J Clin Pract; 2016 May; 70(5):389-95. PubMed ID: 27121158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
